VMD
Viemed Healthcare, Inc.
VMD's fundamentals are strong: revenue grew 22% and free cash flow more than tripled. At 24x earnings, it's trading in line with its usual 26x. Analysts expect earnings growth, though they disagree widely on how much.
VMD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
VMD's revenue, profitability, cash flow and balance sheet are all currently healthy.
VMD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $6.92 | -24% |
| Forward | 18x | $9.11 | — |
| Current | 24x | $9.11 | — |
| Fair | 26x | $9.97 | +9.4% |
| Expensive | 36x | $13.67 | +50% |
Historical ranges are pointers, not guarantees.
VMD's PE is in its fair range at 24x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
VMD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for VMD, with profitability holding steady. However, they disagree widely on these estimates.
VMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.50 | +32% |
| Q3 2026 | $0.38 | +15% |
| Q2 2026 | $0.36 | +5.9% |
| Q1 2026 | $0.37 | +23% |
| Q4 2025 | $0.37 | +32% |
| Q3 2025 | $0.33 | +27% |
| Q2 2025 | $0.34 | +48% |
| Q1 2025 | $0.30 | +20% |
| Q4 2024 | $0.28 | +12% |
VMD's earnings per share have fallen from their peak: $0.38 over the past year, against $0.78 in late 2020.
VMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $80.7M | +12% |
| Q2 2026 | $78.1M | +24% |
| Q1 2026 | $75.4M | +28% |
| Q4 2025 | $76.2M | +26% |
| Q3 2025 | $71.9M | +24% |
| Q2 2025 | $63.1M | +15% |
| Q1 2025 | $59.1M | +17% |
| Q4 2024 | $60.7M | +20% |
VMD's revenue has grown year over year for 20 quarters in a row: $81M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.6% | +0.8 points |
| Q2 2026 | 5.7% | -2.4 points |
| Q1 2026 | 5.7% | -0.8 points |
| Q4 2025 | 11% | +0.4 points |
| Q3 2025 | 7.8% | -1.8 points |
| Q2 2025 | 8.1% | +1.5 points |
| Q1 2025 | 6.5% | +2.1 points |
| Q4 2024 | 11% | +0.2 points |
VMD's operating margin was 8.6% last quarter, up 0.8 points from the same quarter a year ago.
VMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.9M | -73% |
| Q2 2026 | $7.4M | +80% |
| Q1 2026 | $1.4M | +$14M |
| Q4 2025 | $9.7M | +207% |
| Q3 2025 | $10.7M | +516% |
| Q2 2025 | $4.1M | +231% |
| Q1 2025 | -$12.6M | -$7.8M |
| Q4 2024 | $3.2M | -41% |
VMD generated $21M in free cash flow over the past year, about four times what it generated the year before.
VMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +66.6K shares |
| 1 year | +1.7% | +697K shares |
| 3 years | +1.9% | +772K shares |
| 5 years | +1.3% | +533K shares |
| Available history | +3.6% | +1.4M shares |
VMD has 41M diluted shares, up 1.7% from a year ago, despite $8M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $977,000 |
| Q2 2026 | $5.3M |
| Q1 2026 | $1.4M |
| Q4 2025 | — |
| Q3 2025 | $11.6M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
VMD spent $8M buying back its own shares over the past year.
VMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
VMD has more cash than debt.
VMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.9 | Neutral |
| Stochastic | 27.9 | Neutral |
VMD's weekly RSI is 45 (neutral) and its Stochastic is 28 (neutral).
VMD PE vs Healthcare Sector
| Metric | VMD | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 26x | 7.3% below |
| PE % | 39 | 29 | 10 pts above |
VMD is trading at 24x earnings, in line with the Healthcare sector's median of 26x.
VMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.34 | 2.5% below |
| 20 week MA | $9.90 | 8% below |
| 50 week MA | $9.25 | 1.5% below |
| 100 week MA | $8.16 | 12% above |
| 200 week MA | $8.23 | 11% above |
VMD has slipped below its 8-, 20- and 50-week averages, though it's still 11% above its 200-week average.
VMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.28 | $8.00 | +27% |
| 2021 | $8.00 | $5.59 | -30% |
| 2022 | $5.59 | $7.45 | +33% |
| 2023 | $7.45 | $7.85 | +5.4% |
| 2024 | $7.85 | $8.16 | +3.9% |
| 2025 | $8.16 | $7.30 | -11% |
| 2026 YTD | $7.30 | $9.11 | +25% |
VMD has finished higher in four of the last six years. It's up 25% so far in 2026.